PharmChem, Inc.
PCHM
$3.40
$0.0270.80%
OTC PK
| 09/30/2003 | 06/30/2003 | 03/31/2003 | 12/31/2002 | 09/30/2002 | |
|---|---|---|---|---|---|
| Revenue | -10.73% | -16.30% | -15.88% | -17.72% | -24.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.73% | -16.30% | -15.88% | -17.72% | -24.87% |
| Cost of Revenue | -25.37% | -27.50% | -27.42% | -30.28% | -9.41% |
| Gross Profit | 159.12% | 81.99% | 87.76% | 98.65% | -74.78% |
| SG&A Expenses | -24.92% | -24.69% | -32.26% | -35.02% | -10.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -76.92% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.32% | -26.91% | -28.88% | -31.75% | -9.82% |
| Operating Income | 85.18% | 78.64% | 85.29% | 90.96% | -405.56% |
| Income Before Tax | 56.62% | 39.56% | 80.99% | 85.75% | 72.07% |
| Income Tax Expenses | 100.00% | 100.00% | 107.69% | 20.69% | -164.61% |
| Earnings from Continuing Operations | 54.31% | 36.67% | 80.47% | 86.34% | 74.04% |
| Earnings from Discontinued Operations | -100.00% | -100.00% | -100.00% | 364.06% | 580.47% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -136.05% | -208.69% | 50.23% | 139.43% | 136.00% |
| EBIT | 85.18% | 78.64% | 85.29% | 90.96% | -405.56% |
| EBITDA | 119.04% | 115.80% | 118.85% | 122.14% | -987.79% |
| EPS Basic | -136.05% | -208.69% | 50.28% | 139.41% | 135.99% |
| Normalized Basic EPS | 79.68% | 72.18% | 79.94% | 85.01% | -343.98% |
| EPS Diluted | -137.97% | -212.57% | 48.91% | 139.03% | 135.52% |
| Normalized Diluted EPS | 79.74% | 72.18% | 79.94% | 85.01% | -339.72% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.01% | 0.03% | 0.12% |
| Average Diluted Shares Outstanding | 0.30% | 0.00% | 0.01% | 0.03% | -0.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |